There is a peculiar disconnect playing out at Rocket Lab right now. On one side of the ledger sits a company executing with the kind of operational rhythm that would have seemed like science fiction a decade ago. On the other sits a stock that has spent the past week getting punished — not for anything the company did, but for a filing made by its biggest rival.
The catalyst for Friday’s slide was an FCC notification from SpaceX regarding an Iridium satellite arrangement, a regulatory move that rippled through the entire space sector and dragged Rocket Lab’s shares down 4.1 percent to close at 55.60 euros. It was, by most accounts, a sector-wide sell-off rather than a company-specific story. But it landed on already fragile technical footing: the stock is now down 11 percent on the week and 9.6 percent year-to-date, with a Relative Strength Index of 34.8 pointing to oversold conditions.
A Production Machine in Overdrive
The irony is that the operational calendar tells a very different story. On August 21, Rocket Lab launched its 93rd Electron mission from Launch Complex 1 in New Zealand, carrying another QPS-SAR Earth-observation satellite for Japanese customer iQPS. That marked the ninth payload delivered for iQPS, with nine more dedicated launches already booked through 2030 — the kind of repeat business that legacy aerospace players once could only envy.
The momentum extends well beyond Electron. Just days earlier, on August 19, the first eight of 17 satellite platforms built by Rocket Lab for MDA Space reached orbit under a $143 million contract, with commissioning underway to support Globalstar’s direct-to-device communications services. The company has also been quietly strengthening its position in secure communications: on August 18, it joined the Space Data Network Consortium under the US Space Force’s umbrella, securing two delivery orders worth a combined $12 million for the SDN-B optical communications program.
That follows its earlier participation in the broader NITE-STAR framework agreement, a program with a total ceiling of $981 million under which Rocket Lab can now compete for individual task orders.
The Numbers Tell One Story, the Chart Another
The second-quarter results, published August 10, reinforce the picture of a business scaling up: revenue of $234 million, a backlog of $2.36 billion, and more than a billion dollars in new contracts signed during and after the quarter. Management guided third-quarter revenue to a range of $250–265 million, a midpoint of $257.5 million that came in above analyst consensus.
Yet the market’s attention has drifted toward two structural questions that no quarterly print can answer. The first is the planned acquisition of Iridium Communications, announced in late June. The deal represents a strategic pivot of the first order — but it also demands that investors trust management to simultaneously develop a launch vehicle, scale a satellite business, and absorb a multi-billion-dollar merger. That is a heavy ask, and the nervousness around it has been palpable.
Should investors sell immediately? Or is it worth buying Rocket Lab?
The second, and arguably more consequential, question is Neutron.
Neutron: The Window Tightens
Rocket Lab’s answer to the growing competition in the medium-lift segment remains the single biggest swing factor for the stock. Production of the first-stage tanks is reportedly on schedule for delivery to the launch pad in the fourth quarter of 2026, but the company itself acknowledges the year-end window is getting tighter. A first-stage tank crack during testing has already contributed to repeated delays, pushing the earliest possible launch into Q4.
CEO Peter Beck has tried to reframe the conversation, urging investors to focus less on the exact debut date and more on how quickly the company can reach its tenth flight after the first. The message is clear: cadence, not the debut itself, is where the value will be created. CFO Adam Spice has added that a successful test flight could push the company into positive adjusted operating territory in the following quarter.
Meanwhile, the technological side projects continue to accumulate. Optical communications terminals built by Rocket Lab are currently being tested aboard KSAT’s Hyperion satellite as part of the hybrid HYPER-Network, which combines radio and optical links.
A Tale of Two Timelines
The technical picture offers little comfort to short-term traders. The stock sits roughly 18 percent below its 50-day moving average and 20 percent below its 200-day average — a chart that looks nothing like the operational dynamism of recent weeks. Annualized volatility stands at 73 percent, a reminder that this remains a high-beta name in a sector prone to sharp sentiment swings.
But zoom out, and the narrative shifts. Over twelve months, the shares are still up 35 percent, suggesting the recent weakness reads more like a correction than a fundamental re-rating. The question now is whether that gap between operational progress and share price performance closes — and that will depend largely on how convincingly Rocket Lab can execute on two fronts simultaneously: getting Neutron to the pad and integrating Iridium without stumbling.
Ad
Rocket Lab Stock: Buy or Sell?! New Rocket Lab Analysis from August 29 delivers the answer:
The latest Rocket Lab figures speak for themselves: Urgent action needed for Rocket Lab investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 29.
Rocket Lab: Buy or sell? Read more here...
